Lasofoxifene Tartrate | Interleukin Related interleukin-related.com

Product Name :
Lasofoxifene Tartrate

Search keywords :
Lasofoxifene (tartrate)

drugId :
null

Target Vo:
Estrogen receptors

Target Vo Short Name :
ERs

Moa_Name:
Estrogen receptor alpha modulators

First Approval Country :
EU

First Approval Date Filter:
2009

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Azure Biotech Inc

Active Indication_Name:
Menopausal symptoms

In Active Indication_Name:
Bone Diseases, Metabolic

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-HA tag Rabbit mAb Description
Efbemalenograstim alfa Purity
Phospho-EGFR (Tyr1173) Antibody: Phospho-EGFR (Tyr1173) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1173). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts